Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daragh Heitzman

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 26, 2014
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristicsHiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
Annals of Neurology|September 29, 2025
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes AssessmentIkjae Lee, Grace Jang, Ying Kuen Ken Cheung, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 28, 2022
Primary lateral sclerosis natural history study - planning, designing, and early enrollmentHiroshi Mitsumoto, Grace Jang, Ikjae Lee, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 26, 2014
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristicsHiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
Annals of Neurology|September 29, 2025
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes AssessmentIkjae Lee, Grace Jang, Ying Kuen Ken Cheung, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 28, 2022
Primary lateral sclerosis natural history study - planning, designing, and early enrollmentHiroshi Mitsumoto, Grace Jang, Ikjae Lee, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Pageof 4